Yeast Infection Treatment News
Doctors Claim Adam Lambert’s Yeast Infection Was Spread By Word Of Mouth
Word of Adam Lambert’s yeast infection has spread by word of mouth says Dr. Molrat F. Finnegan who examined the Ex-American Idol using a special bio-hazard suit and a 10-foot pole.
“Whenever the human mouth comes in contact with a bacteria like a Candida, it can spread like wildfire. In Mr. Lambert’s case it was a freakin’ hurricane!” Claims Finnegan.
Mexican pharmacy no prescription needed
The publicist for Lambert disclaims the diagnosis as Candida, and added that, ‘Dear Adam’ merely has a sore lip from licking toilet seats as a practical joke for friends…He was just joking around!
Serious accusations popped up when Lambert was spotted wearing a surgical mask as he tried to shoo away a pack of cats that followed him into the popular night spot. Soon after, patrons began to complain of a foul odor and itching lips.
Treatment for recurrent yeast infection
How do you treat recurrent yeast infection? The patient has normal blood sugar and responds to fluconazole (Diflucan), butoconazole (Gynazole), or terconazole (Terazol), but the symptoms return. I would like a standard of care that addresses treatment using longer therapy and maintenance for prevention after symptoms are resolved.—NANCY J. YOUNG, MSN, Greensboro, N.C.
The CDC Web site lists treatment options for recurrent vulvovaginal candidiasis. A general vaginal culture should be done to confirm the diagnosis and determine whether an atypical yeast species is responsible. Ensuring that the right species is treated can help alleviate each clinical episode and prevent recurrences. Some experts recommend a longer duration of initial therapy or repeat treatments (e.g., seven to 14 days of topical therapy or three doses of fluconazole every third day rather than single-dose therapy) to ensure full remission. Maintenance regimens are only recommended once expanded therapy has failed. Maintenance regimens, also available on the CDC Web site, include weekly oral fluconazole for six months or topical clotrimazole once or twice per week. Beyond checking blood sugar, history-taking and relevant labs should also be used to rule out other immunosuppressive conditions like HIV. Also check that your patient is not using vaginal products or other agents that can cause or exacerbate candidiasis.—Lisa Stern, APRN (143-4)
Chemistry able to prevent oral yeast infection
While studying unique chemical signaling pathways among microorganisms in the human mouth, a team of OU researchers may have discovered something much greater: a better way of treating infectious diseases, which could help lessen the risk of creating new antibiotic-resistant superbugs.
Professor Robert Cichewicz of the Department of Chemistry and Biochemistry and his collaborator Professor Felicia Qi from OU Health Sciences Center’s College of Dentistry led a team of chemists and microbiologists who discovered that a certain microorganism, Streptococcus mutans, can inhibit the growth of the pathogenic yeast Candida albicans.
The inhibition of pathogenic substances is a relatively new concept. Over the years, the direct killing of pathogenic substances has led to resistant strains of bacteria, also known as superbugs.
“By inhibiting yeast this way, we can potentially inhibit the selection for resistant strains of yeast that could result in even more severe diseases,” Cichewicz said.
Traditional antibiotics could be reserved for more extreme cases.
Candida albicans exists in two stages: a relatively harmless yeast phase in which the microbe does not cause damage to the body and a pathogenic filamentous phase that has the capability of invading human tissue, Cichewicz said.
“We have discovered a molecule that inhibits a yeast cell’s morphological transformation into the latter — the filamentous phase,” Cichewicz said.
Thrush, a disease caused by human pathogenic yeast, occurs during this phase. It often appears as a white film that can be seen in the oral region, and it typically occurs in immunologically compromised individuals.
“Newborns, HIV patients, organ transplant recipients — these are all groups where thrush is likely to present itself,” Cichewicz said.
Postdoctoral fellows Matt Joyner and Trevor Ellis, graduate student Xiaoru Wang and research associate Jarrod King, all from chemistry and biochemistry, played critical roles discovering the molecule and chemically characterizing the new structure.
“Cichewicz and his team are leaders in this field,” Arthur Edison, professor of biochemistry and microbiology at the University of Florida said. “He has discovered entirely new approaches to studying the complex relationship between organisms. It’s difficult isolating and studying just one organism, but to be able to study two or more which are in entirely different kingdoms is amazing.”
This project was in collaboration with OU’s College of Dentistry.
“Dentistry will change as a field because of work like this,” Qi said. “Traditionally, we look at a problem of, say, teeth, and we come up with a mechanical solution – replacement of the teeth, etc. Now, with this work, we can attack the core issues that lead to poor dental health: the microorganisms themselves.”
The treatment is far from clinical trials, but interest is emerging quickly in this area of research.
“This could be an important tool for creating a fundamental shift in how we view the treatment of harmful microorganisms, and it has only been in the literature for a relatively short time,” Cichewicz said. “The National Institutes of Health and other medical research organizations are very interested in promoting research in areas such as this.”